Ofelia Cruz - Concepedia

Author

Ofelia Cruz

Hospital Sant Joan de Déu Barcelona ORCID

Also Known As

A Cañete, Cheeu Ofelia Cruz, Lidija Kitanovski, M. Vinci, McKeown, Tara, O CRUZ, O Cruz, O Cruz Martínez, O. Cruz, O. Cruz Martinez

183

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Sant Joan de Déu Barcelona University College London Universitat de Barcelona Charles University Institut Gustave Roussy

About

Ofelia Cruz is an author at Hospital Sant Joan de Déu Barcelona specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	1.7K
2	Health Sciences	5	5	576
3	Public Health	1	1	58
4	Cell Biology	1	1	178
5	Immunology	1	1	11

Ofelia Cruz

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma Kathryn R. Taylor, Alan Mackay, Nathalène Truffaux, Nature Genetics Neuro-oncologySomatic VariantTumor HeterogeneityPathologyAcvr1 Mutations	2014	514
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas Ana Guerreiro Stücklin, Scott Ryall, Kohei Fukuoka, Nature Communications	2019	346
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas Álvaro Lassaletta, Michal Zápotocký, Matthew Mistry, Journal of Clinical Oncology Pediatric Brain TumorsTumor InnervationPathologyPediatric Low-grade GliomasPrognostic Implications	2017	328
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma Jaime Gállego Pérez‐Larraya, Marc García-Moure, Sara Labiano, New England Journal of Medicine	2022	243
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells Maria Vinci, Anna Burford, Valeria Molinari, Nature Medicine Neuro-oncologyPediatric Brain TumorsSubclonal PopulationsGliomaTumor Heterogeneity	2018	178
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features Maximilian Deng, Martin Sill, Jason Chiang, Acta Neuropathologica PathologyNeurologyNeuropathologyMedicineGlioma	2018	163
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report Astrid Gnekow, David Walker, Daniela Kandels, European Journal of Cancer	2017	141
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition Liana Nobre, Michal Zápotocký, Vijay Ramaswamy, JCO Precision Oncology	2020	130
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma Diana Carvalho, Kathryn R. Taylor, Nagore G. Olaciregui, Communications Biology	2019	118
Fluorinated Pyrimidines VI. Effects of 5-Fluorouridine and 5-Fluoro-2'-Deoxyuridine on Transplanted Tumors. C. Heidelberger, Lois Griesbach, Ofelia Cruz, Experimental Biology and Medicine Tumor BiologyMedicinal ChemistryOncologyLow DosePharmacology	1958	106

Page 1